Actinium-225, a weapon for the fight against cancer

This virtual evening lecture will be given by Sven Van den Berghe, Chief Executive Officer of Pantera, a joint-venture between SCK CEN and IBA.
https://www.sckcen.be/en/news/iba-and-sck-cen-launch-pantera
The potential of actinium-225
Actinium-225 possesses the resounding potential to treat cancers more effectively. Initial results show that the theranostic radioisotope completely eliminates cancer cells, rather than just inhibiting tumour growth. The risk of recurrence also appears to decrease. To date, extensive research and numerous studies are underway which aim to tackle both high prevalence cancers including prostate, lung, colon, breast, pancreatic, blood (leukemia and other rare forms) and kidney cancers, but also rarer forms of cancer like glioblastoma, the deadliest form of a very invasive brain cancer.
Presentation material
Please log in ( https://bnsorg.be/login/ ) with your BNS member account to get access to the slides and to see the password for the video recording.
2.13.0.02.13.0.0